← Back to Search

Behavioural Intervention

EGS Delirium Recovery Program for Post-Surgery Delirium

N/A
Recruiting
Led By Ben Zarzaur, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Discharged to home or sub-acute rehabilitation
Adult age 65 years and older
Must not have
A history of dementing illnesses and other neurodegenerative disease such as Alzheimer's disease (AD), Parkinson disease, or vascular dementia, or current prescription of anti-dementia medication, or ruled out by Functional Activities Questionnaire (FAQ) score defining dementia; a history of significant traumatic brain injury
Have any spinal cord injury with persistent neurologic deficit at the time of study enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months, 12 months, and 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether the Emergency General Surgery Delirium Recovery Model can help people recover better from delirium. It will last 18 months.

Who is the study for?
This trial is for adults aged 65 or older who have had emergency abdominal surgery, experienced delirium before discharge, and can consent to participate. They must speak English and have access to a phone or internet device. Excluded are those with certain neurodegenerative diseases, severe brain injuries, cancer with short life expectancy, recent substance abuse issues, or undergoing chemotherapy/radiation.
What is being tested?
The study tests the EGS Delirium Recovery Model's effectiveness in aiding cognitive, physical and psychological recovery after surgery-related delirium in older patients. Participants will be involved for 18 months and engage with recovery programs alongside regular questionnaires.
What are the potential side effects?
Since this trial involves a recovery program rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience discomfort or fatigue from engaging in the activities of the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was sent home or to a rehab center after hospital discharge.
Select...
I am 65 years old or older.
Select...
I had emergency abdominal surgery, such as for a bowel issue or ulcer.
Select...
I experienced confusion or delirium before leaving the hospital.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have no history of Alzheimer's, Parkinson's, or significant brain injury.
Select...
I have a spinal cord injury with lasting nerve damage.
Select...
I have had a serious brain injury or stroke recently.
Select...
I have been told I have a short time to live due to cancer.
Select...
I am currently undergoing chemotherapy or radiation therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months, 12 months, and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 12 months, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in overall cognitive recovery
Secondary study objectives
Change in overall physical recovery
General Anxiety Disorder-7 (GAD-7) .
Patient Health Questionnaire-9 (PHQ-9)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment2 Interventions
Participants will receive the usual rehabilitation and post-operative care.
Group II: DANE Recovery ModelExperimental Treatment1 Intervention
The delivery of the model will occur in five phases that correspond to the known stages of recovery after surgery. During the acute stage (0 - 1 month after surgery), participants will undergo the initial case review and two initial virtual visits, and the development of the recovery care plan. During the recovery (2 - 6 months after surgery) and maintenance (7-12 months after surgery) stages, the participants will undergo the interaction phase of the DANE Recovery Model.

Find a Location

Who is running the clinical trial?

SwedishAmerican HospitalUNKNOWN
National Institute on Aging (NIA)NIH
1,789 Previous Clinical Trials
28,187,804 Total Patients Enrolled
37 Trials studying Delirium
38,719 Patients Enrolled for Delirium
University of Wisconsin, MadisonLead Sponsor
1,231 Previous Clinical Trials
3,199,357 Total Patients Enrolled
5 Trials studying Delirium
8,576 Patients Enrolled for Delirium

Media Library

EGS Delirium Recovery Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05373017 — N/A
Delirium Research Study Groups: DANE Recovery Model, Usual Care
Delirium Clinical Trial 2023: EGS Delirium Recovery Program Highlights & Side Effects. Trial Name: NCT05373017 — N/A
EGS Delirium Recovery Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05373017 — N/A
~340 spots leftby Jan 2028